Body Composition

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate

clay bodies for soda.

Thursday, August 31, 2023 - 10:00 PM

Ceramics Monthly; 09/01/2023(AN 169937239); ISSN: 00090328Business Source Corporate Plus

Can We Rely on Resting Metabolic Rate Equations? Large Variance in Crohn Disease Pediatric Patients.

Thursday, August 31, 2023 - 10:00 PM

Journal of pediatric gastroenterology and nutrition; 09/01/2023(AN 37378956); ISSN: 1536-4801MEDLINE Ultimate

Circulating progranulin in human infants: relation to prenatal growth and early postnatal nutrition.

Thursday, August 31, 2023 - 10:00 PM

Pediatric research; 09/01/2023(AN 37031297); ISSN: 1530-0447MEDLINE Ultimate

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month lo...

Thursday, August 31, 2023 - 10:00 PM

Diabetes, obesity & metabolism; 09/01/2023(AN 37246799); ISSN: 1463-1326MEDLINE Ultimate